Developer docs
API playgroundTry for free, no card

Search company profiles

Nevoa

Full company profile

uuid0002rcv

Namestring
Nevoa
Legal namestring
Nevoa Inc.
Websiteurl
nevoainc.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Nevoa Inc. is a privately held medical device company founded in 2009 in Gilbert, Arizona, that develops automated surface disinfection systems for healthcare facilities. Its core product platform centers on two fogging devices, the Nimbus whole-room automated fogging robot and the Stratus handheld fogger, both of which dispense Microburst, a proprietary EPA-registered, pH-neutral hypochlorous acid (HOCl) solution that the company describes as 80 to 100 times more effective than bleach. The Nimbus system is patented and positioned as the only hospital-grade surface disinfection system approved for fogging with EPA-registered HOCl, delivering LOG 4-6 efficacy, 100% surface coverage (including shadowed areas that line-of-sight UV systems miss), and a 2-minute application plus 1-minute contact time that permits immediate room re-entry, unlike hydrogen peroxide vapor systems. Microburst features a patented mixing cap that eliminates shelf-life expiration and is bar-coded for quality control and tracking.

Nevoa sells to US acute-care hospitals, ambulatory surgical centers, and physician offices, addressing Healthcare Associated Infections (HAIs) that the company estimates affect 1.7 million patients and contribute to over 98,000 deaths annually at roughly $28 billion in direct hospital costs. The company operates a direct field-sales GTM with a consultative, demo-driven motion, supported by pilot programs, clinical case studies, content marketing, and the SterileAware podcast. Revenue mechanics combine capital equipment sales (Nimbus, Stratus) with a recurring Microburst consumable stream. Leadership includes CEO Martin McGonagle (formerly GE Healthcare, SC Johnson Professional), co-founder and COO Ernest Cunningham, VP of Sales Peter Hoff, and Clinical Director Connie Addessi (formerly Cardinal Health). Nevoa has raised approximately $16.4 million across four disclosed rounds from 2018 through January 2025.

Short descriptiontext

Nevoa is a privately held Arizona medical device company that sells the Nimbus whole-room fogging robot, the Stratus handheld fogger, and its proprietary EPA-registered Microburst hypochlorous acid solution to US hospitals, ambulatory surgical centers, and physician offices for automated surface disinfection and HAI reduction.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGilbert, United States
HQ citystring
Gilbert
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
automated surface disinfection, healthcare fogging systems, hypochlorous acid disinfectant, hospital infection prevention, environmental hygiene equipment
Industry4 codes
PRIMARYHLAHANAD
Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHSAEAHAC
Healthcare Facility & Medical Office Disinfection
Home & Personal Services/Home Cleaning & Housekeeping/Disinfection/Sanitization & Biohazard Cleaning
SECONDARYHSAEAHAD
Electrostatic Spraying & Fogging Services
Home & Personal Services/Home Cleaning & Housekeeping/Disinfection/Sanitization & Biohazard Cleaning
SECONDARYCRAJANAD
Aerosol Disinfectants & Foggers
NAICS code4 codes
  • Soap and Cleaning Compound Manufacturing32561
  • Polish and Other Sanitation Good Manufacturing325612
  • Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing333413
  • Soap, Cleaning Compound, and Toilet Preparation Manufacturing3256
SIC code2 codes
  • Specialty Cleaning, Polishing And Sanitation Preparations2842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Healthcare Surface Disinfection Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Fogging Equipment Sales
TypeHardware Sales
Description

Sale of Nimbus and Stratus fogging devices to healthcare facilities for automated surface disinfection

nevoainc.com
2Consumables (Microburst Solution)
TypeUsage Based
Description

Ongoing sales of proprietary Microburst HOCl disinfectant solution for use with fogging systems. Patented mixing cap ensures no shelf life expiration.

nevoainc.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales
Pricing details1 tier
1Equipment and consumables with no upfront capital required mentioned as a pilot option
ModelOtherBilling cadenceMulti-year contract
Notes

Nevoa offers a low-cost, risk-free pilot program with no long-term commitment required. Contact-based quoting for equipment and consumables.

nevoainc.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Nevoa designs, manufactures, and sells automated fogging disinfection hardware (Nimbus whole-room robot and Stratus handheld fogger) together with a proprietary EPA-registered hypochlorous acid (Microburst) consumable, sold primarily to U.S. healthcare facilities for automated environmental surface disinfection and Healthcare Associated Infection reduction. Revenue is anchored by equipment sales and ongoing consumable usage tied to those devices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 99.9999% microbial reduction on treated surfaces in 1 minute
+5 more records
Product overview1 text field

Nevoa offers a unified portfolio of automated surface disinfection products for healthcare facilities, consisting of two fogging devices and a proprietary disinfectant solution. The flagship Nimbus is an automated whole-room fogging robot that provides comprehensive environmental surface disinfection using Microburst hypochlorous acid solution. The compact Stratus handheld fogger delivers the same advanced disinfection capability in a portable form factor for between-case applications in operating rooms and procedure areas. Both devices utilize Microburst, Nevoa's proprietary EPA-registered HOCl solution, which achieves 99.9999% microbial reduction on treated surfaces in just one minute. The portfolio is designed to automate and enhance healthcare facility disinfection protocols, reducing manual labor while improving consistency and efficacy.

Product and service3 records
1Nimbus
CategoryAutomated Surface Disinfection Equipment
Description

Patented, automated whole-room fogging robot and surface disinfection system, the only one approved for fogging with EPA-registered hypochlorous acid (HOCl). Delivers LOG 4-6 efficacy, achieves 300x better disinfection than manual cleaning alone, uses 64% less labor for terminal cleaning, and enables immediate room re-entry after each cycle. Sold to hospitals, ambulatory surgical centers, and physician offices.

2Stratus
CategoryHandheld Surface Disinfection Equipment
Description

Compact, lightweight (4.4 lbs) handheld fogger powered by Microburst HOCl solution for advanced surface disinfection between surgical cases. Features rechargeable battery and easy-fill reservoir, achieves comprehensive surface coverage in 2 minutes of application plus 1 minute of contact time, and kills 99.9999% of pathogens including Staph, MRSA, and Pseudomonas.

3Microburst
CategoryHospital-Grade Disinfectant Consumable
Description

Nevoa's proprietary EPA-registered, hospital-grade hypochlorous acid (HOCl) consumable that is 80x to 100x more effective than bleach. pH-neutral, non-toxic, environmentally safe, 100% biodegradable, with no shelf life due to its patented mixing cap and bar-coded for quality control and data tracking. Used as the recurring consumable with both Nimbus and Stratus fogging systems.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Two Arizona Hospitals (Validation Partners)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Two Arizona hospitals validated the Nimbus Disinfection Protocol efficacy for pathogen reduction. These hospital partnerships provided clinical validation of the disinfection system's effectiveness in real healthcare settings.

nevoainc.com
Strategic tierMinorTypeOthers
Description

Nevoa partner profile featuring Job Options, a disability services organization. Details of the partnership arrangement are limited.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Ecolab's healthcare division provides cleaning, sanitization, and disinfection products and services to hospitals globally, overlapping with Nevoa's infection-prevention and surface-disinfection proposition at a much larger scale.

TypeBroad incumbent
Description

Bioquell's hydrogen peroxide vapor systems, now part of Ecolab, compete in the same hospital room bio-decontamination space as Nevoa and serve as a broad-incumbent reference point for the category.

3STERIS
TypeBroad incumbent
Description

STERIS is a large medical-device and sterilization company with infection-prevention products reaching the same hospital customers Nevoa sells into, providing both competition and an M&A comparable.

TypeDirect peer
Description

Xenex makes LightStrike UV robots for hospital room disinfection — the most direct competitor to Nevoa's Nimbus in the automated healthcare-facility disinfection category, targeting the same EVS and infection-control buyers.

TypeBroad incumbent
Description

GOJO, the maker of Purell, sells hand-hygiene and surface-disinfection products into hospitals and is a broad-incumbent supplier competing for infection-prevention budget at the same accounts.

TypeBroad incumbent
Description

PDI sells EPA-registered disinfectant wipes, sprays, and surface care products used in hospitals alongside (or instead of) automated systems like Nevoa's — a relevant incumbent in the same infection-prevention category.

7Halosil International
TypeDirect peer
Description

Halosil produces HaloMist hydrogen peroxide-based disinfection systems and HaloFogger devices for healthcare and commercial facilities, making it a direct automated-fogging peer to Nevoa.

TypeDirect peer
Description

Tru-D markets a UV disinfection robot used in hospital terminal cleaning, competing head-to-head with Nevoa's whole-room fogging approach for the same HAI-reduction budget.

TypeDirect peer
Description

TOMI's SteraMist ionized hydrogen peroxide system is another automated whole-room disinfection platform for hospitals and life-sciences facilities, closely comparable to Nimbus in delivery model and buyer.

TypeBroad incumbent
Description

Clorox Healthcare is a major hospital-grade disinfectant brand (bleach and hydrogen peroxide wipes) used in the same EVS workflows that Nevoa targets, representing the manual-cleaning incumbents Nevoa aims to displace.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nevoa

Healthcare Surface Disinfection Equipmentnevoainc.com

Nevoa is a privately held Arizona medical device company that sells the Nimbus whole-room fogging robot, the Stratus handheld fogger, and its proprietary EPA-registered Microburst hypochlorous acid solution to US hospitals, ambulatory surgical centers, and physician offices for automated surface disinfection and HAI reduction.

What Nevoa does

Nevoa Inc. is a privately held medical device company founded in 2009 in Gilbert, Arizona, that develops automated surface disinfection systems for healthcare facilities. Its core product platform centers on two fogging devices, the Nimbus whole-room automated fogging robot and the Stratus handheld fogger, both of which dispense Microburst, a proprietary EPA-registered, pH-neutral hypochlorous acid (HOCl) solution that the company describes as 80 to 100 times more effective than bleach. The Nimbus system is patented and positioned as the only hospital-grade surface disinfection system approved for fogging with EPA-registered HOCl, delivering LOG 4-6 efficacy, 100% surface coverage (including shadowed areas that line-of-sight UV systems miss), and a 2-minute application plus 1-minute contact time that permits immediate room re-entry, unlike hydrogen peroxide vapor systems. Microburst features a patented mixing cap that eliminates shelf-life expiration and is bar-coded for quality control and tracking.

Nevoa sells to US acute-care hospitals, ambulatory surgical centers, and physician offices, addressing Healthcare Associated Infections (HAIs) that the company estimates affect 1.7 million patients and contribute to over 98,000 deaths annually at roughly $28 billion in direct hospital costs. The company operates a direct field-sales GTM with a consultative, demo-driven motion, supported by pilot programs, clinical case studies, content marketing, and the SterileAware podcast. Revenue mechanics combine capital equipment sales (Nimbus, Stratus) with a recurring Microburst consumable stream. Leadership includes CEO Martin McGonagle (formerly GE Healthcare, SC Johnson Professional), co-founder and COO Ernest Cunningham, VP of Sales Peter Hoff, and Clinical Director Connie Addessi (formerly Cardinal Health). Nevoa has raised approximately $16.4 million across four disclosed rounds from 2018 through January 2025.

Nevoa firmographics

Firmographics
Name
Nevoa
Legal name
Nevoa Inc.
Website
https://nevoainc.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Nevoa is a privately held Arizona medical device company that sells the Nimbus whole-room fogging robot, the Stratus handheld fogger, and its proprietary EPA-registered Microburst hypochlorous acid solution to US hospitals, ambulatory surgical centers, and physician offices for automated surface disinfection and HAI reduction.
Ownership category
akta.pro rank

Nevoa industry classification

Industry
Product category
Healthcare Surface Disinfection Equipment
NAICS
Soap and Cleaning Compound Manufacturing (32561), Polish and Other Sanitation Good Manufacturing (325612), Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)
SIC
Specialty Cleaning, Polishing And Sanitation Preparations (2842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHANAD
Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHSAEAHAC
Healthcare Facility & Medical Office Disinfection
Home & Personal Services/Home Cleaning & Housekeeping/Disinfection/Sanitization & Biohazard Cleaning
SECONDARYHSAEAHAD
Electrostatic Spraying & Fogging Services
Home & Personal Services/Home Cleaning & Housekeeping/Disinfection/Sanitization & Biohazard Cleaning
SECONDARYCRAJANAD
Aerosol Disinfectants & Foggers

Keywords

  • Automated surface disinfection
  • Healthcare fogging systems
  • Hypochlorous acid disinfectant
  • Hospital infection prevention
  • Environmental hygiene equipment

Where Nevoa is headquartered

Location

Headquarters

HQ city
Gilbert
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Nevoa business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales

Revenue model

  1. Fogging Equipment Sales: Sale of Nimbus and Stratus fogging devices to healthcare facilities for automated surface disinfection
  2. Consumables (Microburst Solution): Ongoing sales of proprietary Microburst HOCl disinfectant solution for use with fogging systems. Patented mixing cap ensures no shelf life expiration.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEquipment and consumables with no upfront capital required mentioned as a pilot option

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Nevoa product offering

Product offering

Core offering

Nevoa designs, manufactures, and sells automated fogging disinfection hardware (Nimbus whole-room robot and Stratus handheld fogger) together with a proprietary EPA-registered hypochlorous acid (Microburst) consumable, sold primarily to U.S. healthcare facilities for automated environmental surface disinfection and Healthcare Associated Infection reduction. Revenue is anchored by equipment sales and ongoing consumable usage tied to those devices.

Product overview

Nevoa offers a unified portfolio of automated surface disinfection products for healthcare facilities, consisting of two fogging devices and a proprietary disinfectant solution. The flagship Nimbus is an automated whole-room fogging robot that provides comprehensive environmental surface disinfection using Microburst hypochlorous acid solution. The compact Stratus handheld fogger delivers the same advanced disinfection capability in a portable form factor for between-case applications in operating rooms and procedure areas. Both devices utilize Microburst, Nevoa's proprietary EPA-registered HOCl solution, which achieves 99.9999% microbial reduction on treated surfaces in just one minute. The portfolio is designed to automate and enhance healthcare facility disinfection protocols, reducing manual labor while improving consistency and efficacy.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nimbus Patented, automated whole-room fogging robot and surface disinfection system, the only one approved for fogging with EPA-registered hypochlorous acid (HOCl). Delivers LOG 4-6 efficacy, achieves 300x better disinfection than manual cleaning alone, uses 64% less labor for terminal cleaning, and enables immediate room re-entry after each cycle. Sold to hospitals, ambulatory surgical centers, and physician offices.
  • Stratus Compact, lightweight (4.4 lbs) handheld fogger powered by Microburst HOCl solution for advanced surface disinfection between surgical cases. Features rechargeable battery and easy-fill reservoir, achieves comprehensive surface coverage in 2 minutes of application plus 1 minute of contact time, and kills 99.9999% of pathogens including Staph, MRSA, and Pseudomonas.
  • Microburst Nevoa's proprietary EPA-registered, hospital-grade hypochlorous acid (HOCl) consumable that is 80x to 100x more effective than bleach. pH-neutral, non-toxic, environmentally safe, 100% biodegradable, with no shelf life due to its patented mixing cap and bar-coded for quality control and data tracking. Used as the recurring consumable with both Nimbus and Stratus fogging systems.

Quantifiable outcome

  • 99.9999% microbial reduction on treated surfaces in 1 minute
  • +5 more outcomes

Companies that use Nevoa

Customer profile

Segments3 records

Ideal customer profiles3 records

Nevoa technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Nevoa partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Two Arizona Hospitals (Validation Partners)coreStrategic or Co-development PartnerTwo Arizona hospitals validated the Nimbus Disinfection Protocol efficacy for pathogen reduction. These hospital partnerships provided clinical validation of the disinfection system's effectiveness in real healthcare settings.
  • Job OptionsminorOthersNevoa partner profile featuring Job Options, a disability services organization. Details of the partnership arrangement are limited.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Nevoa competitors and assessment

Company assessment

Broad incumbents

  • Ecolab Healthcare: Ecolab's healthcare division provides cleaning, sanitization, and disinfection products and services to hospitals globally, overlapping with Nevoa's infection-prevention and surface-disinfection proposition at a much larger scale.
  • Bioquell (Ecolab): Bioquell's hydrogen peroxide vapor systems, now part of Ecolab, compete in the same hospital room bio-decontamination space as Nevoa and serve as a broad-incumbent reference point for the category.
  • STERIS: STERIS is a large medical-device and sterilization company with infection-prevention products reaching the same hospital customers Nevoa sells into, providing both competition and an M&A comparable.
  • GOJO Industries (Purell): GOJO, the maker of Purell, sells hand-hygiene and surface-disinfection products into hospitals and is a broad-incumbent supplier competing for infection-prevention budget at the same accounts.
  • PDI Healthcare: PDI sells EPA-registered disinfectant wipes, sprays, and surface care products used in hospitals alongside (or instead of) automated systems like Nevoa's — a relevant incumbent in the same infection-prevention category.
  • Clorox Healthcare: Clorox Healthcare is a major hospital-grade disinfectant brand (bleach and hydrogen peroxide wipes) used in the same EVS workflows that Nevoa targets, representing the manual-cleaning incumbents Nevoa aims to displace.

Direct peers

  • Xenex Disinfection Services: Xenex makes LightStrike UV robots for hospital room disinfection — the most direct competitor to Nevoa's Nimbus in the automated healthcare-facility disinfection category, targeting the same EVS and infection-control buyers.
  • Halosil International: Halosil produces HaloMist hydrogen peroxide-based disinfection systems and HaloFogger devices for healthcare and commercial facilities, making it a direct automated-fogging peer to Nevoa.
  • Tru-D SmartUVC: Tru-D markets a UV disinfection robot used in hospital terminal cleaning, competing head-to-head with Nevoa's whole-room fogging approach for the same HAI-reduction budget.
  • TOMI Environmental Solutions: TOMI's SteraMist ionized hydrogen peroxide system is another automated whole-room disinfection platform for hospitals and life-sciences facilities, closely comparable to Nimbus in delivery model and buyer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Nevoa social profiles

Digital presence

Nevoa compliance and trust

Trust signal

Compliance2 records

Nevoa financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nevoa leadership team

Management profile

Number of profiles

Profiles4 records

Nevoa funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nevoa M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nevoa

What does Nevoa do?

Nevoa designs, manufactures, and sells automated fogging disinfection hardware (Nimbus whole-room robot and Stratus handheld fogger) together with a proprietary EPA-registered hypochlorous acid (Microburst) consumable, sold primarily to U.S. healthcare facilities for automated environmental surface disinfection and Healthcare Associated Infection reduction. Revenue is anchored by equipment sales and ongoing consumable usage tied to those devices.

Is Nevoa a public or private company?

Nevoa is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Nevoa founded?

Nevoa was founded in 2009. It employs 11 to 50 people.

Where is Nevoa based?

Nevoa is headquartered in Gilbert, United States, in the North America region.

How does Nevoa make money?

Two revenue lines are on record. Fogging Equipment Sales are the primary driver. The others are consumables (Microburst Solution).

Who are Nevoa's main competitors?

Broad incumbents on record are Ecolab Healthcare, Bioquell (Ecolab), STERIS, GOJO Industries (Purell), PDI Healthcare and Clorox Healthcare. Direct peers are Xenex Disinfection Services, Halosil International, Tru-D SmartUVC and TOMI Environmental Solutions.

Does Nevoa have an API?

No public API is recorded for Nevoa.

What industry is Nevoa in?

Nevoa's product category is Healthcare Surface Disinfection Equipment. Its primary akta.pro industry code is HLAHANAD, Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots), with a secondary code of HSAEAHAC, Healthcare Facility & Medical Office Disinfection. Its NAICS code is 32561 and its SIC code is 2842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals